Buprenorphine Dose Alteration Study - 1

University of Vermont

Status and phase: Completed; Phase 1

Conditions: Opioid-Related Disorders

Treatments: Drug: Buprenorphine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000219

R01-06969-1

NIDA-06969-1

R18DA006969 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to examine the effects in buprenorphine dose alterations in opioid dependent individuals being maintained on buprenorphine.

Sex: Male

Ages: 19 to 41 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.